Stock Taper

Pricing Sign Up Log In

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF • Roundhill Investments

$32.90 ▲ 1.76% (+0.57)

Managing Company Roundhill Investments

Asset Under Management $63.14M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $37.15

52w Low $23.22

Volume 5,427

Avg Volume 23,962

Asset Class Equity

About Roundhill Investments - GLP-1 & Weight Loss ETF

Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an...

Managing Company Roundhill Investments

Asset Under Management $63.14M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $37.15

52w Low $23.22

Volume 5,427

Avg Volume 23,962

Asset Class Equity

About Roundhill Investments - GLP-1 & Weight Loss ETF

Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an...

HOLDINGS (Top 20)

Stock	Name	Weight	Shares	Market Value
NVO	Novo Nordisk A/S	13.33%	168.98K	$8.29M
LLY	Eli Lilly and Company	12.24%	6.61K	$7.61M
PFE	Pfizer Inc.	6.46%	165.70K	$4.02M
VKTX	Viking Therapeutics, Inc.	5.73%	93.82K	$3.56M
KLRA	Kailera Therapeutics, Inc.	5.39%	176.24K	$3.35M
AMGN	Amgen Inc.	3.79%	6.63K	$2.36M
AZN	AstraZeneca PLC	3.34%	12.62K	$2.08M
GPCR	Structure Therapeutics Inc.	2.89%	35.56K	$1.80M
MBX	MBX Biosciences, Inc. Common Stock	2.88%	31.68K	$1.79M
GILD	Gilead Sciences, Inc.	1.79%	8.57K	$1.11M
RYTM	Rhythm Pharmaceuticals, Inc.	1.62%	9.19K	$1.01M
WVE	Wave Life Sciences Ltd.	0.92%	92.94K	$569.71K

SECTOR HOLDINGS

Healthcare

Healthcare

100.00%

ASSET ALLOCATION BY REGION

United States

43.15%

Denmark

18.89%

China

18.27%

Japan

5.56%

South Korea

3.46%

United Kingdom

3.40%

Switzerland

2.99%

Hong Kong

2.78%

Singapore

0.91%

Other

0.60%

SECTOR HOLDINGS

Healthcare

Healthcare

100.00%

ASSET ALLOCATION BY REGION

United States

43.15%

Denmark

18.89%

China

18.27%

Japan

5.56%

South Korea

3.46%

United Kingdom

3.40%

Switzerland

2.99%

Hong Kong

2.78%

Singapore

0.91%

Other

0.60%

Holdings (Top 20)

NVO

NVO

Novo Nordisk A/S

Weight: 13.33% Shares: 168.98K Value: $8.29M

LLY

LLY

Eli Lilly and Company

Weight: 12.24% Shares: 6.61K Value: $7.61M

PFE

PFE

Pfizer Inc.

Weight: 6.46% Shares: 165.70K Value: $4.02M

VKTX

VKTX

Viking Therapeutics, Inc.

Weight: 5.73% Shares: 93.82K Value: $3.56M

KLRA

KLRA

Kailera Therapeutics, Inc.

Weight: 5.39% Shares: 176.24K Value: $3.35M

AMGN

AMGN

Amgen Inc.

Weight: 3.79% Shares: 6.63K Value: $2.36M

AZN

AZN

AstraZeneca PLC

Weight: 3.34% Shares: 12.62K Value: $2.08M

GPCR

GPCR

Structure Therapeutics Inc.

Weight: 2.89% Shares: 35.56K Value: $1.80M

MBX

MBX

MBX Biosciences, Inc. Common Stock

Weight: 2.88% Shares: 31.68K Value: $1.79M

GILD

GILD

Gilead Sciences, Inc.

Weight: 1.79% Shares: 8.57K Value: $1.11M

RYTM

RYTM

Rhythm Pharmaceuticals, Inc.

Weight: 1.62% Shares: 9.19K Value: $1.01M

WVE

WVE

Wave Life Sciences Ltd.

Weight: 0.92% Shares: 92.94K Value: $569.71K